With a market cap of has a large market cap size. Eli Lilly and Company (NYSE: LLY) has been on the stock market since its IPO date on the 6/1/1972. Eli Lilly and Company is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for Eli Lilly and Company, is 3983.21, and so far today it has a volume of 1077640. Performance year to date since the 6/1/1972 is -3.41%.
To help you determine whether Eli Lilly and Company is undervalued the following values will help you decide. P/E is 34.39 and forward P/E is 19.51. PEG perhaps more useful shows that Eli Lilly and Company has a value for PEG of 2.63. P/S ratio is 4.29 and the P/B ratio is 5.76. The P/Cash and P/Free cash flow is 22.48 and *TBA respectively.
At the current price Eli Lilly and Company is trading at, 79.2 (-0.73% today), Eli Lilly and Company has a dividend yield of 2.56%, and this is covered by a payout ratio of 91.20%. Earnings per share (EPS) is 2.32, and this is looking to grow in the next year to 13.99% after growing 1.60% this past year. EPS growth quarter over quarter is 25.10%, and 8.60% for sales growth quarter over quarter.
The number of shares outstanding is 1108.52, and the number of shares float is 1101.58. The senior management bring insider ownership to 11.40%, and institutional ownership is at 77.40%. The float short is 0.77%, with the short ratio at a value of 2.14. Management has seen a return on assets of 6.90%, and also a return on investment of 9.50%.
The ability for Eli Lilly and Company, to deal with debt, means it current ratio is 1.5, and quick ratio is 1.1. Long term debt/equity is 0.59 and total debt/equity is 0.64. In terms of margins, Eli Lilly and Company has a gross margin of 73.70%, with its operating margin at 14.60%, and Eli Lilly and Company has a profit margin of 12.00%.
The 52 week high is -12.43%, with 18.20% being its 52 week low. The 20 day simple moving average is 1.01% and the 200 day simple moving average is 2.75%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.